These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20868351)

  • 1. ACE inhibitors for the treatment of hypertension drug selection by means of the SOJA method.
    Edgar L; Hogg A; Scott M; Timoney M; Mc Elnay J; Mairs J; Janknegt R
    Rev Recent Clin Trials; 2011 Jan; 6(1):69-93. PubMed ID: 20868351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion.
    Janknegt R; Steenhoek A
    Drugs; 1997 Apr; 53(4):550-62. PubMed ID: 9098659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.
    Alabbadi I; Crealey G; Scott M; Baird S; Trouton T; Mairs J; McElnay J
    Clin Drug Investig; 2006; 26(9):485-94. PubMed ID: 17163281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
    Zannad F; Matzinger A; Larché J
    Am J Hypertens; 1996 Jul; 9(7):633-43. PubMed ID: 8806975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
    Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
    J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.
    Diamant M; Vincent HH
    J Hum Hypertens; 1999 Jun; 13(6):405-12. PubMed ID: 10408591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the angiotensin-converting-enzyme inhibitors.
    Piepho RW
    Am J Health Syst Pharm; 2000 Oct; 57 Suppl 1():S3-7. PubMed ID: 11030016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
    Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing the right ACE inhibitor. A guide to selection.
    Leonetti G; Cuspidi C
    Drugs; 1995 Apr; 49(4):516-35. PubMed ID: 7789286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications.
    Hermida RC; Ayala DE; Fernández JR; Portaluppi F; Fabbian F; Smolensky MH
    Am J Hypertens; 2011 Apr; 24(4):383-91. PubMed ID: 20930708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
    J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant responses to two classes of drugs acting on the renin-angiotensin system.
    Sever PS; Chang CL
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.